Bioprinted tissue therapeutics company Aspect Biosystems has closed a $115 million Series B financing round.   The financing was led by Dimension, and included Novo Nordisk, Radical Ventures, an undisclosed leading global investment firm, InBC, Pallasite Ventures, Pangaea Ventures, Rhino Ventures, and T1D Fund: A Breakthrough T1D Venture.  This builds on CA$200 million ($139 million) partnership […]